WeTrials
Recruiting

A Phase I Trial Combining Triapine With Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

What is this study?

This early-stage study tests a new combination treatment for brain tumors like glioblastoma and astrocytoma that have returned after previous care. Researchers want to find the safest and most effective dose of an experimental drug called Triapine when used alongside radiation therapy.

Who can participate?

Adults with confirmed brain tumors (such as recurrent astrocytomas or glioblastomas grades 2 through 4) whose tumors are a specific size may be eligible. Participants must also have recovered from past treatment side effects and meet certain medical health criteria.

What will happen?

Participants will receive the experimental drug Triapine combined with specialized radiation therapy to target the cancer. Throughout the process, doctors will monitor your health closely using imaging scans and small tissue or fluid tests.

Where and when?

This study is currently recruiting patients and takes place at multiple locations in California, United States including Duarte, Irvine, and La Jolla.

Key Points
  • 1Combines an experimental drug called Triapine with radiation therapy
  • 2Aims to safely treat brain tumors that have returned after previous treatments
  • 3Currently recruiting patients at several medical centers in California

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Astrocytoma, IDH-Mutant, Grade 2Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-MutantRecurrent Adult Diffuse Midline Glioma, H3 K27-MutantRecurrent Astrocytoma, IDH-MutantRecurrent Astrocytoma, IDH-Mutant, Grade 3Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma, IDH-Wildtype

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.